US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit
US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
More Stories
President Trump Announces New Tariffs on Canada, Mexico, and China
Gold Price Today: What’s Behind the Spike in Price?
Ex-Federal Reserve Employee Caught Selling Trade Secrets for Over a Decade